LSDIF (Lucy Scientific Discovery) Inventories, Finished Goods: $0.00 Mil (As of Dec. 2023)


What is Lucy Scientific Discovery Inventories, Finished Goods?

Lucy Scientific Discovery LSDIF Inventories, Finished Goods is $0.00 Mil as of Dec. 2023.

Lucy Scientific Discovery Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Lucy Scientific Discovery's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lucy Scientific Discovery Inventories, Finished Goods Chart

Lucy Scientific Discovery Annual Data
Trend Jun21 Jun22 Jun23
Inventories, Finished Goods
0.00 0.00 0.00

Lucy Scientific Discovery Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Lucy Scientific Discovery Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of $0.00 Mil mean?
Lucy Scientific Discovery (LSDIF) has a Inventories, Finished Goods of $0.00 Mil as of Dec. 2023. Finished goods are inventory items that are complete and ready to be sold. View historical data on Lucy Scientific Discovery and its competitors.
Is Lucy Scientific Discovery's Inventories, Finished Goods too high?
Lucy Scientific Discovery's current Inventories, Finished Goods is $0.00 Mil.
How does Lucy Scientific Discovery's Inventories, Finished Goods compare to INQD and ZTS?
Lucy Scientific Discovery's Inventories, Finished Goods of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Lucy Scientific Discovery and its competitors. Lucy Scientific Discovery's current Inventories, Finished Goods is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lucy Scientific Discovery stock overvalued right now?
Lucy Scientific Discovery (LSDIF) has a current Inventories, Finished Goods of $0.00 Mil. The current Inventories, Finished Goods is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Lucy Scientific Discovery (LSDIF), the current Inventories, Finished Goods is $0.00 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lucy Scientific Discovery Business Description

Address 301-1321 Blanshard Street, Victoria, BC, CAN, V8W 0B6
Lucy Scientific Discovery Inc is an early-stage psychotropics contract manufacturing company focused on becoming the contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. Its drug products are designed to treat a range of mental health and cognitive conditions.